4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000004
CFO AND TREASURER sold 21,000 shares at an average $436.09 ($9,157,821)
- CFO AND TREASURER acquired 21,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-04 | Exercise or conversion : show line 1 in the form 10b5-1 | +21,000 | $146.03 | $3,066,630 | 29,118 | D |
| 2025-11-04 | Sale : show line 2 in the form 10b5-1 | −98 | $432.09 | $42,345 | 29,020 | D |
| 2025-11-04 | Sale : show line 3 in the form 10b5-1 | −1,074 | $432.86 | $464,892 | 27,946 | D |
| 2025-11-04 | Sale : show line 4 in the form 10b5-1 | −1,512 | $433.78 | $655,872 | 26,434 | D |
| 2025-11-04 | Sale : show line 5 in the form 10b5-1 | −1,679 | $434.96 | $730,302 | 24,755 | D |
| 2025-11-04 | Sale : show line 6 in the form 10b5-1 | −6,088 | $435.81 | $2,653,239 | 18,667 | D |
| 2025-11-04 | Sale : show line 7 in the form 10b5-1 | −7,317 | $436.78 | $3,195,910 | 11,350 | D |
| 2025-11-04 | Sale : show line 8 in the form 10b5-1 | −2,752 | $437.74 | $1,204,662 | 8,598 | D |
| 2025-11-04 | Sale : show line 9 in the form 10b5-1 | −360 | $438.50 | $157,859 | 8,238 | D |
| 2025-11-04 | Sale : show line 10 in the form 10b5-1 | −120 | $439.51 | $52,741 | 8,118 | D |
| Open-market sales · 21,000 sh · avg $436.09 · $9,157,821 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-11-04 | Exercise or conversion : show line 11 in the form 10b5-1 Stock Options | −21,000 | $146.03 | 2027-03-15 | 21,000 | 31,312 | D |
Loading xslF345X05/primarydocument.xml…